CLINICAL OUTCOMES OF PRIMARY PERCUTANEOUS CORONARY INTERVENTION USING DES VS BMS In ACUTE CORONARY SYNDROME PATIENTS WITH LEFT ANTERIOR DESCENDING ARTERY INVOLVEMENT: A COMPARATIVE STUDY

Authors

  • T DURRANI Department of Cardiology, Northwest General Hospital and Research Center, Peshawar, Pakistan
  • A QADEER Department of Cardiology Rehman Medical Institute, Peshawar, Pakistan
  • M JUNAID Department of Cardiology Rehman Medical Institute, Peshawar, Pakistan
  • I HUSSAIN Department of Cardiology Hayatabad Medical Complex, Peshawar, Pakistan
  • F KHAN Department of Cardiology, Northwest General Hospital and Research Center, Peshawar, Pakistan
  • H DURRANI Department of Cardiology Hayatabad Medical Complex, Peshawar, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2024i1.1155

Keywords:

Acute coronary syndrome, percutaneous coronary intervention, left anterior descending artery, drug-eluting stent, bare-metal stent, major adverse cardiovascular events.

Abstract

Acute coronary syndrome (ACS) with left anterior descending (LAD) artery involvement often leads to more extensive myocardial infarction. Choosing between drug-eluting stents (DES) and bare-metal stents (BMS) for revascularisation in these patients is a topic of clinical relevance. While drug-eluting stents are the gold standard, bare-metal stents remain an essential option for patients with specific considerations such as an inability to complete the recommended duration of DAPT, advanced age, concomitant oral anticoagulation, cancer, affordability issues, increased bleeding risk, and planned noncardiac surgery within the next year. Objective: This study aimed to compare the clinical outcomes of ACS patients with LAD involvement treated with either DES or BMS during primary PCI.Methods: A retrospective cohort study was conducted between January 1, 2021, and December 31, 2023, at a tertiary care center. A total of 200 ACS patients with LAD involvement who underwent primary PCI were included. Patients were grouped based on the type of stent used (DES or BMS). Data on patient demographics, comorbidities, procedural details, and outcomes were collected. Major adverse cardiovascular events (MACE), including all-cause mortality, myocardial infarction (MI), and target lesion revascularisation (TLR), were assessed. Kaplan-Meier survival analysis and Cox proportional hazards models were used to analyse outcomes. Results: MACE occurred in 48 patients (24%) during the one-year follow-up. Patients treated with DES experienced significantly fewer events (p < 0.001) compared to those receiving BMS. Diabetes mellitus and chronic kidney disease were independent predictors of adverse outcomes (p = 0.006 and p < 0.001, respectively).Conclusion: Primary PCI using DES in ACS patients with LAD involvement is associated with better clinical outcomes compared to BMS, particularly in high-risk populations. These findings suggest that DES should be the preferred stent type for this patient group to reduce adverse events and improve long-term survival.

Downloads

Download data is not yet available.

References

Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2018;39(2):119-177. doi:10.1093/eurheartj/ehx393

Dehghani P, Kabul HK, Yan RT, et al. Association of primary percutaneous coronary intervention and mortality in patients with ST-elevation myocardial infarction. Heart. 2014;100(9):677-683. doi:10.1136/heartjnl-2013-305153

Stone GW, Maehara A, Lansky AJ, et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med. 2011;364(3):226-235. doi:10.1056/NEJMoa1002358

Sabatine MS, Cannon CP, Gibson CM, et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med. 2005;352(12):1179-1189. doi:10.1056/NEJMoa050522

Park DW, Yun SC, Lee SW, et al. Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of the MAIN-COMPARE study. J Am Coll Cardiol. 2014;64(11):1072-1080. doi:10.1016/j.jacc.2014.06.1190

Wijns W, Kolh P, Danchin N, et al. Guidelines on myocardial revascularization. Eur Heart J. 2010;31(20):2501-2555. doi:10.1093/eurheartj/ehq277

Bonnefoy E, Lapostolle F, Leizorovicz A, Steg G, McFadden EP, Dubien PY, et al. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study. Lancet. 2002 Sep 14;360(9336):825-9. doi: 10.1016/S0140-6736(02)09963-4. PMID: 12243916.

Kirtane AJ, Doshi D, Leon MB, et al. Treatment of higher-risk patients with an indication for revascularization: evolution within the field of contemporary percutaneous coronary intervention. Circulation. 2016;134(5):422-431. doi:10.1161/CIRCULATIONAHA.116.022061

Sabatine MS, Cannon CP, Gibson CM, et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med. 2005;352(12):1179-1189. doi:10.1056/NEJMoa050522

Park DW, Yun SC, Lee SW, et al. Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of the MAIN-COMPARE study. J Am Coll Cardiol. 2014;64(11):1072-1080. doi:10.1016/j.jacc.2014.06.1190

Mehilli J, Byrne RA, Tiroch K, et al. Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 3 study. Eur Heart J. 2010;31(20):2448-2456. doi:10.1093/eurheartj/ehq288

Ahn JM, Park DW, Lee CW, et al. Comparison of stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease in the drug-eluting stent era (MAIN-COMPARE): a matched cohort analysis. Lancet. 2007;369(9560):753-760. doi:10.1016/S0140-6736(07)60342-3

Stone GW, Maehara A, Lansky AJ, et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med. 2011;364(3):226-235. doi:10.1056/NEJMoa1002358

Bangalore S, Kumar S, Fusaro M, et al. Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117,762 patient-years of follow-up from randomized trials. Circulation. 2012;125(23):2873-2891. doi:10.1161/CIRCULATIONAHA.111.063644

Mehran R, Dangas GD, Abizaid AS, et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation. 1999;100(18):1872-1878. doi:10.1161/01.CIR.100.18.1872

Dangas GD, Serruys PW, Kereiakes DJ, et al. In-stent restenosis in coronary bare-metal stents: a risk score from patient-level pooled analysis of 10,004 patients. J Am Coll Cardiol. 2010;55(10):895-903. doi:10.1016/j.jacc.2009.08.088

Cutlip DE, Windecker S, Mehran R, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115(17):2344-2351. doi:10.1161/CIRCULATIONAHA.106.685313

Downloads

Published

2024-09-29

How to Cite

DURRANI , T., QADEER , A., JUNAID , M., HUSSAIN , I., KHAN , F., & DURRANI , H. (2024). CLINICAL OUTCOMES OF PRIMARY PERCUTANEOUS CORONARY INTERVENTION USING DES VS BMS In ACUTE CORONARY SYNDROME PATIENTS WITH LEFT ANTERIOR DESCENDING ARTERY INVOLVEMENT: A COMPARATIVE STUDY. Biological and Clinical Sciences Research Journal, 2024(1), 1155. https://doi.org/10.54112/bcsrj.v2024i1.1155

Most read articles by the same author(s)

<< < 1 2 3 > >>